Investors Grab MTNB 9.7% Lower Than Its Secondary Stock Offering
January 13, 2020 at 10:00 AM EST
Looking back to 3 days ago, Matinas BioPharma Holdings Inc (MTNB) priced a 32,260,000 share secondary stock offering at $1.55 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
